14:00 EST GLP-1 drugs helping normalize obesity treatment, ReShape CEO tells The Fly
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RSLS:
- ReShape engages Maxim Group to identify M&A partnership alternatives
- ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
- ReShape Lifesciences: FDA approves a PMA supplement for Lap-Band 2.0 FLEX
- ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
- ReShape Lifesciences price target lowered to $1 from $4 at Maxim
